Miya shishini davolash uchun sehrli elektr maydoni

Miya shishini davolash uchun sehrli elektr maydoni, dunyodagi eng yaxshi miya shishini davolash. Miya shishi bilan kasallangan bemorlarni davolashda sehrli elektr maydon terapiyasining narxi. Miya shishini davolash narxi.

Ushbu xabarni baham ko'ring

Miya shishini davolash uchun sehrli elektr maydoni bo'yicha so'nggi ishlanmalar mavjud.

Glioblastoma - bu "tugatuvchi" deb nomlanadigan o'lik kasallik, chunki bu o'sma juda tez o'sadi va har qanday yoshdagi, yomon prognoz bilan kasallanishi mumkin.

There is currently no cure for this tumor, and treatment is difficult because glioblastomas extend the antennae into the brain instead of forming a solid mass that a doctor can target and remove. So even if the surgical resection is clean, the average time to shish recurrence is only 6.9 months, and the average survival time is only 14.6 months. During the treatment process, resistance to traditional treatment is prone to occur. What is more frightening is that this kind of Tumors have a curse that has a nearly 100% chance of recurrence.

Yaqinlashib kelayotgan shaytonga tayyorgarlik - tanangizni asta-sekin egib oling

61 yoshli Skott Rider Uilyamsportda yashaydi. U nafaqaga chiqqan va xotini va amakivachchasi bilan birga yashaydi va yoqimli nabirasi bor.

Bir kuni u yuvinib yuvinib o'tirganicha tanasi suyanib turganday tuyuldi ...

U nima bo'lganini bilmas edi, lekin keyingi kunlarda ishlar tobora yomonlashib bordi. U hech narsa qilmasa ham juda charchagan va juda charchaganligini his qila boshladi.

The family was a little worried whether it would be Alzheimer’s disease. He accompanied him to the hospital for a systematic examination. After the diagnosis, the whole family was shocked. Rider got one of the most deadly miya shishi, glioblastoma, but The predicted life can only be calculated in months, not years.

In April 2017, with the support of his family, he underwent surgery. The doctor said that at present the lesions were cut clean, but the fatality of this brain tumor is that it will definitely recur, but sooner or later the problem, so still You need to receive radiotherapy and chemotherapy as soon as possible to kill the remaining cancer cells in the body to the greatest extent and delay the recurrence as much as possible.

"Sehrli" elektr maydon - takrorlanish sehrini ko'taring

Kimyoterapiya paytida, Riderning davolovchi shifokori, FDA endilikda bemorning qirib tashlangan bosh terisiga biriktirilgan to'rtta elektrod yostig'idan tashkil topgan yangi davolash usulini, ya'ni Optune deb ham ataladigan elektr maydon terapiyasini tasdiqladi. U translyator massivi tomonidan glioblastoma o'smasi joylashgan joyga uzatiladigan past intensivlikdagi, past chastotali elektr maydonini hosil qiladi.

Electric fields can destroy rapidly dividing cancer cells, especially glioma, a type of tumor that divides rapidly.

Mr. Rider uses MRI to monitor brain tumors every other month. He said, “In the best case, it would shrink, but for me it didn’t grow anymore, it was very stable, which was very good.

Endi Rider "sehrli kuch" bilan ishlaydigan elektr maydoni unga takrorlanadigan la'natni ko'taradi va bu uning hayotini saqlab qoluvchi "xayrixoh".

U birinchi marta glioblastomani tashxis qilganida, shifokorlar uning atigi 18-24 oylik hayoti borligini aytganini eslaydi. Biroq, hozirda operatsiyadan 27-oy o'tdi va takrorlanish alomatlari yo'q, u doimo elektr maydonini kiyib yurishini aytdi, shunda ham u ishini davom ettirishi mumkin.

Janob Rider ishlashga muhtoj bo'lmaganda, u eng sevimli sport turlari, masalan chang'i va xokkey bilan shug'ullanadi. U uyda bo'lganida, u ham sevimli nabirasi bilan o'ynagan. Bu elektr maydon terapiyasining sehridir. Bu sizning tanangizdagi saraton hujayralarini butunlay normal hayot sharoitida boshqarishga imkon beradi. Hujayralar va atrofdagi odamlar salbiy ta'sirga ega.

Janob Rider uning muvaffaqiyati boshqalarga umid baxsh etadi deb umid qilmoqda. "Menda xavfli miya shishi kabi o'lik o'smani engish uchun hech qanday yo'lim yo'q, ammo ijobiy hayot kechirishim mumkin".

Elektr maydon terapiyasi-FDA tomonidan tasdiqlangan yangi davolash texnologiyasi

Optune FDA tomonidan tasdiqlangan va ko'plab sug'urtalar bilan qoplanadi.

 

Hozirgi vaqtda elektr maydon terapiyasi FDA tomonidan quyidagilar uchun tasdiqlangan:

1. Treatment of adult patients with unresectable, locally advanced or metastatic mezoteliyoma (MPM), can be used with pemetrexed and platinum chemotherapy.

2. Adult patients (22 years or older) for histologically confirmed ko'p shaklli glioblastoma (GBM).

3. Voyaga etgan bemorlarda yangi tashxis qo'yilgan glioblastomani davolash uchun kombinatsiyalangan temozolomid.

4. Kimyoterapiya o'tkazilgandan so'ng takroriy gliomalar uchun elektr maydon terapiyasini yolg'iz qabul qilish mumkin.

The use of alternating low-intensity electric fields can destroy tumor cells and reduce damage to healthy tissues, which can effectively prevent side effects from affecting patients’ quality of life. Since 2000, the R & D team has been developing and expanding indications for electric field therapy. At present, researchers are conducting clinical trials on common solid tumors, including non-small cell lung cancer, non-small cell lung cancer brain metastasis, pancreatic cancer has launched phase III clinical trials, ovaryan saraton and mesothelioma have completed phase II clinical trials, will soon Entered Phase III trials, and liver cancer is undergoing Phase II trials. These cancers have achieved very exciting clinical data.

Optune o'simta davolash elektr maydoni - bu o'smani davolashning yangi sxemasi. Bu ma'lum bir elektr maydon chastotasidan foydalanib, hujayraning bo'linishiga to'sqinlik qiladi, o'smaning o'sishini inhibe qiladi va elektr maydonidan ta'sirlangan saraton hujayralarini o'lishiga olib keladi. In vitro va in vivo jonli tadqiqotlar shuni tasdiqladiki, o'simta davolashning elektr maydonlari o'simta hujayralarining mitozini inhibe qilish orqali o'smaning o'sishini kechiktirishi va qaytarishi mumkin.

Taniqli miya shishi mutaxassisi doktor Rojer Stupp bir vaqtlar shunday degan edi:

“Yigirma yil oldin, men glioblastomani davolashni boshlaganimda, bemorlarning aksariyati bir yildan kamroq vaqt ichida vafot etdi va uzoq muddatli omon qolish holatlari deyarli yo'q edi. Shish maydonini davolash temozolomid bilan birlashtirilganligi sababli, har 7 bemordan biri 5 yildan ortiq yashadi. "

Bundan tashqari, o'smaning elektr maydonini davolash samarasi muvofiqlik bilan chambarchas bog'liq. Bemorlar kuniga 22 soatdan ko'proq kiyinishganda, besh yillik hayot darajasi 29.3% gacha ko'tarilishi mumkin, bu faqat temozolomidning besh yillik umumiy omon qolish darajasidan 6 baravar ko'pdir! Eng muhimi, ushbu davolash usuli xemoradiatsiya natijasida yuzaga keladigan deyarli hech qanday yon ta'sirga ega emas. Eng keng tarqalgan - bu elektrod yostig'ining aloqa joyidagi toshma. Bu miya shishini davolash tarixida misli ko'rilmagan.

It is reported that Zaiding Pharmaceuticals is submitting an application for special approval of innovative medical devices to the State Drug Administration, and plans to submit an application for electric field therapy to be exempted from clinical trials. At the same time, it has completed a refinancing of US $ 200 million. Introduced Optune, a tumor electric field therapy, to start a new era of non-invasive tumor treatment! At present, you can go to Hong Kong through the Medical Department of Global Oncologist Network, and receive electric field treatment in Japan (400-666-7998)

I look forward to electric field therapy entering mainland China as soon as possible, and hope that this technology that brings huge survival benefits to cancer patients can enter medical insurance as soon as possible and bring the gospel to the majority of patients!

 

Adabiyotlar: https://www.pahomepage.com/news/using-electricity-to-treat-aggressive-brain-tumor/

 

 

 

Bizning xabarnomamizga obuna bo'ling

Yangilanishlarni oling va Cancerfax blogini hech qachon o'tkazib yubormang

Ko'proq o'rganish uchun

Insonga asoslangan CAR T hujayra terapiyasi: yutuqlar va muammolar
CAR T-Cell terapiyasi

Insonga asoslangan CAR T hujayra terapiyasi: yutuqlar va muammolar

Insonga asoslangan CAR T-hujayra terapiyasi saraton hujayralarini nishonga olish va yo'q qilish uchun bemorning o'z immun hujayralarini genetik jihatdan o'zgartirish orqali saraton kasalligini davolashda inqilob qiladi. Tananing immun tizimining kuchini ishga solgan holda, bu muolajalar saratonning har xil turlarida uzoq muddatli remissiya potentsialiga ega kuchli va moslashtirilgan davolash usullarini taklif qiladi.

Sitokinlarni ajratish sindromini tushunish: sabablari, belgilari va davolash
CAR T-Cell terapiyasi

Sitokinlarni ajratish sindromini tushunish: sabablari, belgilari va davolash

Sitokinlarni chiqarish sindromi (CRS) - bu immunoterapiya yoki CAR-T hujayra terapiyasi kabi ba'zi davolash usullari bilan qo'zg'atiladigan immunitet tizimining reaktsiyasi. Bu sitokinlarning haddan tashqari chiqarilishini o'z ichiga oladi, bu isitma va charchoqdan tortib organlarning shikastlanishi kabi hayot uchun xavfli asoratlargacha bo'lgan alomatlarni keltirib chiqaradi. Boshqaruv ehtiyotkorlik bilan monitoring va aralashuv strategiyasini talab qiladi.

Yordam kerak? Bizning jamoamiz sizga yordam berishga tayyor.

Yaqiningiz va yaqinlaringizning tezroq sog'ayib ketishini tilaymiz.

Suhbatni boshlang
Biz onlaynmiz! Biz bilan suhbatlashing!
Kodni skanerlang
Salom,

CancerFax-ga xush kelibsiz!

CancerFax ilg'or bosqich saratoniga duchor bo'lgan shaxslarni CAR T-Cell terapiyasi, TIL terapiyasi va butun dunyo bo'ylab klinik sinovlar kabi ilg'or hujayra terapiyalari bilan bog'lashga bag'ishlangan kashshof platformadir.

Siz uchun nima qilishimiz mumkinligini bizga xabar bering.

1) Chet elda saraton kasalligini davolash?
2) CAR T-hujayrali terapiya
3) Saratonga qarshi emlash
4) Onlayn video konsultatsiya
5) Proton terapiyasi